Edgewise Therapeutics
EWTX
EWTX
85 hedge funds and large institutions have $443M invested in Edgewise Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
83% less call options, than puts
Call options by funds: $11K | Put options by funds: $64K
Holders
85
Holding in Top 10
1
Calls
$11K
Puts
$64K
Top Buyers
| 1 | +$4.89M | |
| 2 | +$4.55M | |
| 3 | +$3.33M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$924K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$887K |
Top Sellers
| 1 | -$4.33M | |
| 2 | -$4.33M | |
| 3 | -$2.07M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.04M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$1.68M |